Gsa Capital Partners LLP Fortress Biotech, Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.8 - $1.5 $162,889 - $305,418	-203,612 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.24 - $2.75 $252,478 - $559,933	203,612 New	203,612 $277,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $452,970 - $683,199	-187,178 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.82 - $3.7 $99,029 - $129,932	35,117 Added 23.09%	187,178 $603,000
Q2 2021 Aug 05, 2021	BUY	$3.5 - $5.48 $286,352 - $448,346	81,815 Added 116.47%	152,061 $543,000

Q1 2021 May 10, 2021	BUY	$3.16 - $4.89 $149,524 - $231,385	47,318 Added 206.38%	70,246 $248,000
Q4 2020 Feb 03, 2021	BUY	$2.2 - $4.45 $50,441 - $102,029	22,928 New	22,928 $73,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.